Parapertussis and pertussis: Differences and similarities in incidence, clinical course, and antibody responses
- 1 January 1999
- journal article
- research article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 3 (3) , 140-146
- https://doi.org/10.1016/s1201-9712(99)90035-8
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A Comparative Efficacy Trial in Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine, the Lederle Whole-Cell Component DTP Vaccine, or DT VaccinePediatrics, 1998
- Protective role of immunoglobulin G antibodies to filamentous hemagglutinin and pertactin ofBordetella pertussis inBordetella parapertussis infectionEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- A Placebo-Controlled Trial of a Pertussis-Toxoid VaccineNew England Journal of Medicine, 1995
- Response and Decline of Serum IgG Antibodies to Pertussis Toxin, Filamentous Hemagglutinin and Pertactin in Children with PertussisScandinavian Journal of Infectious Diseases, 1995
- Role of pertussis toxin in causing symptoms ofBordetella parapertussis infectionEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussisThe Pediatric Infectious Disease Journal, 1994
- How common is whooping cough in a nonvaccinating country?The Pediatric Infectious Disease Journal, 1993
- Pathogenesis in Bordetella SpeciesThe Journal of Infectious Diseases, 1990
- Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genesJournal of Bacteriology, 1987
- EPIDEMICS OF PARAPERTUSSIS 20 Years' Observations in DenmarkThe Lancet, 1971